| Title: | Endometrial or Cervical Cancer Radiation Therapy Study |
| Purpose: | The purpose of the study is to test whether the use of an advanced radiation therapy delivery technique called intensity-modulated radiation therapy (IMRT) can spare normal tissue, including small bowel and large bowel, from radiation. The research is being done to try to reduce radiation side effects (especially diarrhea) that occur with the standard radiation methods. |
| Study Number: | 109035 |
| Number of Patients: | 92 |
| Elgibility: |
Eligibility for both endometrial and cervical cancer patients is based on the pathology. Both endometrial and cervical cancer patients must have undergone a hysterectomy within seven weeks prior to study entry.
|
| Treatment: | Patients with endometrial and cervix cancer will get radiation therapy given once a day, five days a week for 28 days. If you have cervical cancer, you also will receive the chemotherapy drug cisplatin during radiation treatments. Five doses of cisplatin will be given starting at the time of radiation. |
| Principal Investigator: |
Kevin Albuquerque, M.D. |
| Enrollment Phone: | (708) 216-2568 |
| |
| |
| |
|
